At the tumor margin, early miR-22 treatment showed upregulated DNA repair, nucleotide excision repair, RNA processing, cholesterol biosynthesis, and polyamine metabolism, but inhibition in axon guidance, nervous system development, TGFβ, Hippo, and β-catenin signaling. This evidence concerns the gene TGFB1 and neoplasm.